Raza Bokhari - Dec 31, 2024 Form 3/A - Amendment Insider Report for Medicus Pharma Ltd. (MDCX)

Role
Chief Executive Officer, Director
Signature
/s/ Raza Bokhari
Stock symbol
MDCX
Transactions as of
Dec 31, 2024
Transactions value $
$0
Form type
3/A - Amendment
Date filed
2/10/2025, 04:55 PM
Date Of Original Report
Dec 31, 2024
Next filing
Jul 24, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MDCX Common Shares, no par value ("Common Shares") 793K Dec 31, 2024 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the number of Common Shares reported to be indirectly held by the Reporting Person.
F2 Held by RBx Capital, LP, an entity controlled by Dr. Raza Bokhari. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.